Search for: "Smithkline Beecham Pharmaceutical Co." Results 1 - 20 of 87
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2011, 9:03 am by Todd B. Scherwin
SmithKline Beecham (No. 10-15257, opinion by Judge Milan D. [read post]
24 Jan 2012, 9:27 am by Amanda Frost
SmithKline Beecham Corp., a case which may lead the Court to revisit whether an agency’s interpretation of its own regulations merit deference. [read post]
25 Jun 2012, 7:08 am by Mitchell Boyarsky
SmithKline Beecham Corp. regarding the scope of this exemption has provided much needed clarity to pharmaceutical companies and employers with similar types of sales forces who have relied – and hope to continue to rely – on the exemption. [read post]
25 Feb 2012, 10:04 am by Schachtman
Smithkline Beecham Corp., 2010 U.S. [read post]
31 Jul 2008, 5:30 pm
SmithKline Beecham Corp., 2007 WL 2726259 (S.D. [read post]
6 Jun 2016, 1:08 pm by Lyle Denniston
The Court’s order sending the case of SmithKline Beecham Corp. v. [read post]
7 Jul 2011, 2:31 pm by Bexis
Smithkline Beecham Corp., 658 N.W.2d 127 (Mich. 2003)) or the Sixth Circuit (Garcia v. [read post]
17 Feb 2011, 1:59 pm by AALRR
  SmithKline Beecham Corporation (“Glaxo”) hired plaintiffs in 2003 to meet with physicians and encourage them to prescribe Glaxo pharmaceuticals. [read post]
18 Jun 2012, 1:38 pm
SmithKline Beecham Corporation that pharmaceutical sales representatives are not entitled to overtime pay under the Fair Labor Standards Act, as reported by the Wall Street Journal. [read post]
5 Apr 2016, 2:12 am by Dennis Crouch
SmithKline Beecham Corp., 791 F.3d 388 (3d Cir. 2015). [2] Supreme Court Docket No. 15-1055. [3] 35 U.S.C. [read post]
14 Dec 2006, 4:08 am
SmithKline Beecham Consumer Health Care LP, No. [read post]
26 Jan 2009, 12:47 am
That is a 29% premium over where the shares closed on Thursday before The Wall Street Journal reported that the two were in talks.With a value of $68 billion, the deal is the largest takeover in the pharmaceutical sector since Glaxo Wellcome PLC acquired SmithKline Beecham PLC for $76 billion in 2000.Wyeth Chief Executive Bernard J. [read post]